Studies have shown that in patients who developed TD, immune marker levels such as Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α) and chemokines are relatively higher and thus in the process may potentially be more effective at achieving SVR [12]. Here, TNF is linked to thanatophoric dysplasia.